Skip to main content
Premium Trial:

Request an Annual Quote

SciNova to Develop Software for AstraZeneca India

This article has been corrected from a previous version, which stated that SciNova was developing software to determine the structure of proteins.

 

NEW YORK, July 21 - SciNova of Pune, India, has been tapped to develop custom software for the Bangalore, India-based AstraZeneca Research Foundation India (AZREFI), Scinova said today.

 

SciNova will work with researchers at AZREFI to develop software that determines the structure of small-molecule natural products based on NMR and mass spec data using a machine-learning approach.

 

SciNova said it would retain rights to market the product in the international market once it is developed.

 

AZREFI is endowed by AstraZeneca Plc, UK, and registered as a non-profit society in the state of Karnataka, India.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.